神经节苷脂对脑外伤大鼠大脑皮质Nogo-A表达的影响
Influence of GM1 on Nogo-A Expression in Cerebral Cortex for the Brain Trauma Rats

作者: 王向东 * , 任新亮 , 郭铁柱 , 王彦宏 , 李建红 , 赵志强 :长治医学院附属和济医院神经外科,山西 长治;

关键词: Nogo-A脑外伤神经节昔脂Nogo-A Brain Trauma Ganglioside (GM1)

摘要:
目的:观察神经节苷脂(GM1)对脑外伤大鼠大脑皮质中Nogo-A表达的影响,探讨GM1促进脑外伤神经修复的可能机制。方法:采用SPF级SD大鼠100只,随机分为空白对照组(n=10)、假手术组(n=20)、损伤后生理盐水组(n=35)和损伤后GM1组(n=35)。通过HE染色观察各组大鼠脑组织不同时间点病理情况;用免疫组化的方法观察Nogo-A阳性细胞数量。结果:通过免疫组化的方法观察损伤后生理盐水组:Nogo-A阳性细胞在造模24时即明显升高,至72h时仍呈升高的趋势;GMl组:Nogo-A的阳性细胞数早期逐渐升高,至24h时数量最多,之后开始减少,应用GMl后,Nogo-A的阳性细胞数量的增加较为延后。结论:Nogo-A在颅脑损伤后其阳性细胞数量显著增高,抑制中枢神经损伤后的再生,神经节苷脂GM1在脑损伤后可部分抑制Nogo-A的表达,机制可能通过稳定细胞膜、减轻细胞水肿,从而发挥对实验性脑外伤大鼠的神经保护作用。

Abstract: Objective: To observe the effects of the ganglioside (GM1) on Nogo-A expression in cerebral cortex for the rats which have brain trauma, to explore the possible mechanisms of GMl promoting the nerve repair of traumatic brain injury. Methods: SPF SD rats of 100 were randomly divided into four groups: no operation group (n=10), sham operation group (n=20), saline model group (n=35), GMI group (n=35). ELISA was used to detect Nogo-A expression in parietal cerebral cortex at different time. Results: By immunohistochemical method we observed in model group: the number Nogo-A positive cells increased at 24 hours in the model, and still slightly increased till 72 hours; in group GM1: the number Nogo-A of positive cells increased gradually in the early time, and became largest at24 h, then started to decrease, the application of GM1, after brain trauma, the increase in the number of Nogo-A positive cells was more delayed. Conclusions: the number of Nogo-A positive cells increased significantly after brain trauma, and inhibited the CNS regeneration after injury. After brain trauma, the ganglioside GM1 partially inhibited Nogo-A expression, and the mechanism might be through the stability of cell membrane, which played its neuroprotection roles in experimental traumatic brain injury in rats.

文章引用: 王向东 , 任新亮 , 郭铁柱 , 王彦宏 , 李建红 , 赵志强 (2015) 神经节苷脂对脑外伤大鼠大脑皮质Nogo-A表达的影响。 国际神经精神科学杂志, 4, 7-12. doi: 10.12677/IJPN.2015.42002

参考文献

[1] Marklund, N., Morales, D., Clausen, F., Hånell, A., Kiwanuka, O., Pitkänen, A., et al. (2009) Functional outcome is im-paired following traumatic brain injury in aging nogo-A/B-deficient mice. Neuroscience, 163, 540-551.
http://dx.doi.org/10.1016/j.neuroscience.2009.06.042

[2] 李计成, 李晓明, 戴如飞, 等 (2013) 单唾液酸四己糖神经节苷脂对颅脑损伤患者血清中神经元特异性烯醇化酶的影响及其临床意义. 实用心脑肺血管病杂志, 2, 36-38.

[3] 张跃, 周明清, 王洋鑫 (2010) 单唾液酸四己糖神经节苷脂对脑卒中患者早期康复的影响. 中国现代医生, 36, 167-185.

[4] 邱观养, 黄丹丹, 邓耀芳, 等 (2013) 神经节苷脂治疗急性脑梗死的临床疗效观察叨. 中国医药指南, 1, 532-533.

[5] 古磊, 甄云 (2012) Nogo-A及其受体NgR 对中枢神经系统损伤后修复的影响. 中国医药导报, 1, 9-11.

[6] 陈大鹏, 王华, 姚裕家 (2006) 缺氧缺血新生鼠脑组织Nogo-A含量变化. 四川医学, 27, 225-227.

[7] Jiang, W., Xia, F., Han, J. and Wang, J. (2009) Patterns of Nogo-A, NgR, and RhoA expression in the brain tissues of rats with focal cerebral infarction. Translational Research, 154, 40-48.
http://dx.doi.org/10.1016/j.trsl.2009.04.005

[8] 刘仁红, 周晓光, 熊爱华, 等 (2007) Nogo-A mRNA在缺氧缺血性脑损伤新生大鼠脑组织中的表达. 中华围产医学杂志, 1, 37-40.

[9] 吴功雄, 张海伟, 徐杰, 等 (2005) 神经生长抑制因子Nogo-A在缺血性脑梗塞大鼠脑组织中的表达. 中国病理生理杂志, 21, 143-147.

[10] Zhou, C.M., Li, Y., Nanda, A. and Zhang, J.H. (2003) HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischaemia. Biochemical and Biophysical Research Communications, 309, 368-376.
http://dx.doi.org/10.1016/j.bbrc.2003.08.006

[11] Mingorance, A., Fontana, X., Soriano, E. and del Río, J.A. (2005) Overexpression of myelin associated glycoprotein after axotomy of the perforant pathway. Molecular and Cellular Neuroscience, 29, 471-483.
http://dx.doi.org/10.1016/j.mcn.2005.03.016

[12] Cheatwood, J.L., Emerick, A.J., Schwab, M.E. and Kartje, G.L. (2008) Nogo-A expression after focal ischemic stroke in the adult rat. Stroke, 39, 2091-2098.
http://dx.doi.org/10.1161/strokeaha.107.507426

[13] Eslamboli, A., Grundy, R.I. and Irving, E.A. (2006) Time-dependent increase in Nogo-A expression after focal cerebral ischemis in marmoset monkeys. Neuroscience Letters, 408, 89-93.
http://dx.doi.org/10.1016/j.neulet.2006.08.056

[14] Maier, I.C., Ichiyama, R.M., Courtine, G., Schnell, L., Lavrov, I., Edgerton, V.R., et al. (2009) Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain, 132, 1426-1440.
http://dx.doi.org/10.1093/brain/awp085

[15] Harel, N.Y., Song, K.H., Tang, X. and Strittmatter, S.M. (2010) Nogo receptor deletion and multimodal exercise improve distinct aspects of recovery in cervical spinal cord injury. Journal of Neurotrauma, 27, 2055-2066.
http://dx.doi.org/10.1089/neu.2010.1491

[16] 朱薇薇, 赵红洋, 温天莲, 等 (2010) 缺氧缺血性脑损伤新生大鼠脑Nogo受体水平及NEPl-4O的神经保护作用.中华儿科杂志, 2, 138-142.

[17] 沈剑虹, 文立, 马进 (2007) 大鼠弥漫性轴索损伤对脑内NgR 表达的影响. 交通医学, 4, 347-349, 354.

[18] 林在楷, 田恒力, 吴炳山, 等 (2010) 急性闭合性颅脑损伤患者血清Nogo-A蛋白的变化. 上海交通大学学报:医学版, 1, 70-72.

[19] 刘晓祥, 杜忠胜, 明大庆, 等 (2007) 神经节苷脂治疗重型颅脑损伤疗效分析(附46例报告). 山东医药, 15, 40-41.

[20] 张彦 (2011) 神经节苷脂联合高压氧治疗新生儿缺氧缺血性脑病125例l临床观察. 山东医药, 12, 87-88.

[21] 王树兴, 彭龙锋, 曲绍霞, 等 (2012) 神经节苷脂对重型颅脑创伤患者血清Nogo-A蛋白水平的影响. 山东医药, 3, 72-74.

[22] 虞欢东, 曹利民, 裴静波 (2014) 神经节苷脂对重型颅脑损伤患者血清S100B蛋白和Nogo-A蛋白水平的影响及疗效观察. 中国医药导报, 6, 59-61.

分享
Top